0 Commentarii
0 Distribuiri
877 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Tyrosine Kinase Inhibitors Market Analysis, Size, Share, Segments & ForecastExecutive Summary Tyrosine Kinase Inhibitors Market Size and Share Analysis Report The global tyrosine kinase inhibitors market size was valued at USD 63.58 billion in 2024 and is projected to reach USD 100.57 billion by 2032, with a CAGR of 5.90% during the forecast period of 2025 to 2032. With the use of few steps or the combination of several steps, the process of...0 Commentarii 0 Distribuiri 462 Views 0 previzualizare
-
Tyrosine Kinase Inhibitors Market Share, Size, Emerging Trends and Forecast AnalysisExecutive Summary Tyrosine Kinase Inhibitors Market Size, Share, and Competitive Landscape The global tyrosine kinase inhibitors market size was valued at USD 63.58 billion in 2024 and is projected to reach USD 100.57 billion by 2032, with a CAGR of 5.90% during the forecast period of 2025 to 2032. This Tyrosine Kinase Inhibitors Market report has been generated by...0 Commentarii 0 Distribuiri 442 Views 0 previzualizare
-
Tyrosine Kinase Inhibitors Market Size, Share and Growth Forecast Report 2032Global Executive Summary Tyrosine Kinase Inhibitors Market: Size, Share, and Forecast Tyrosine Kinase Inhibitors Market Size The global tyrosine kinase inhibitors market size was valued at USD 63.58 billion in 2024 and is projected to reach USD 100.57 billion by 2032, with a CAGR of 5.90% during the forecast period of 2025 to 2032. Tyrosine Kinase Inhibitors Market business report...0 Commentarii 0 Distribuiri 744 Views 0 previzualizare
-
Tyrosine Kinase Inhibitors Market: Size, Share, Growth, Trends, and Forecast to 2032The Global Tyrosine Kinase Inhibitors Market is poised for steady expansion. Valued at USD 63.58 billion in 2024, the market is projected to reach USD 100.57 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.90% from 2025 to 2032. This article provides a thorough analysis of market dynamics, segmentation, drivers, challenges, and competitive insights, drawing...0 Commentarii 0 Distribuiri 743 Views 0 previzualizare
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentarii 0 Distribuiri 123 Views 0 previzualizare
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commentarii 0 Distribuiri 91 Views 0 previzualizare
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Commentarii 0 Distribuiri 76 Views 0 previzualizare
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commentarii 0 Distribuiri 9 Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek